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evidence-based answer
no, in most cases, counseling does  
not prevent postpartum depression 
(PPD), though it can treat the disorder. 
overall, psychosocial interventions 
don’t offer a significantly greater benefit 
than standard care in preventing 
PPD—although studies do suggest a 
preventive benefit when the intervention 
is administered postnatally, in the home, 
and targeted toward individual at-risk 
women (strength of recommendation 
[sor]: a, meta-analysis of 15 
randomized, controlled trials [rcTs] and 
1 subsequent rcT). 
 Psychotherapy and counseling—
including interpersonal therapy, individual 
and group cognitive behavioral therapy 
(cBT), psychodynamic therapy, and 
nondirective counseling—are effective in 
treating PPD (sor: a, systematic review 
of 15 rcTs and 1 later rcT). not enough 
evidence exists to compare the benefits 
of antidepressant medication with cBT 
(sor: B, 2 low-quality rcTs).
clinical commentary
Do some research before you refer
Postpartum depression negatively impacts 
maternal satisfaction and is a major 
women’s health issue. recognizing that 
psychosocial interventions are considered 
first-line, evidence-based treatments is 
important, but, beyond that, knowing how 
to locate a licensed professional who 
delivers these treatments may be critical  
to your patient.
 one way to identify such a clinician is 
to use a Web-based search tool such as 
www.findapsychologist.org, provided  
by the national register of health  
service Providers in Psychology  
(www.nationalregister.org). once identified, 
contact the clinician and ask how s/he 
does what s/he does. If the answer is 
evidence-based treatments, you may have 
a strong candidate for treating a woman 
with PPD. Just remember: a referral is 
as important as the care you, yourself, 
provide.
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z	Evidence	summary
Prevention:	No	overall	benefit,		
but	some	approaches	may	help
A Cochrane meta-analysis of pooled 
data from 15 RCTs (7697 women) 
found that psychological interventions 
didn’t prevent PPD based on comparison 
of initial depression scores with scores 
at the conclusion of the studies (rela-
tive risk [RR]=0.81; 95% confidence 
interval [CI], 0.65-1.02).1 Although 
some studies suggested short-term ben-
efit (N=4091; RR=0.65; 95% CI, 0.43-
1.00), benefits diminished over time and 
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weren’t noted when the definition of de-
pression was limited to an Edinburgh 
Postpartum Depression Scale (EPDS) 
score below 12 (out of a maximum of 
30). Some differences were found when 
the data were stratified.
Certain interventions were found to 
prevent depressive symptoms (defined 
differently in the various studies). They 
were: home visits provided by health-
care professionals (2 RCTs, N=1663; 
RR=0.68; 95% CI, 0.55-0.84), interven-
tions targeting at-risk women (7 RCTs, 
N=1162; RR=0.67; 95% CI, 0.51-0.89), 
and interventions begun postnatally 
(10 RCTs, N=6379; RR=0.76; 95% CI, 
0.58-0.98). Notably, the level of training 
of providers of psychological interven-
tions included in the meta-analysis was 
highly variable. 
A later RCT of a 6-session cognitive-
behavioral, midwife-administered inter-
vention in mothers of preterm infants 
showed no preventive benefit (N=176; 
RR=1.02; 95% CI, 0.87-1.20).2
Treatment:	Counseling	helps,		
especially	in	the	near	term
A recent systematic review of 5 RCTs 
(N=450) investigated the effectiveness of 
interpersonal psychotherapy, CBT (in-
dividual and group), nondirective coun-
seling, and psychodynamic therapy in 
reducing PPD symptoms.3 
interpersonal therapy (12 weekly ses-
sions) significantly reduced PPD symptoms 
as measured by the Hamilton Depression 
Rating Scale (HAM-D) compared with a 
wait-list control group (1 RCT, N=120, 
RR=2.11; 95% CI, 1.04-4.28). 
individual cBT and ideal standard 
care (weekly 20- to 60-minute support-
ive meetings) were equally effective in 
reducing depression scores immediately 
postintervention and 6 months thereaf-
ter as measured by the EPDS (1 RCT, 
N=37). Although a trend toward great-
er benefit for CBT was noted, the study 
was underpowered to identify a signifi-
cant difference. 
nondirective counseling reduced the 
proportion of women with depression 
(N=55; RR=0.49; 95% CI, 0.26-0.95) 
and lowered EPDS scores (N=193; treat-
ment effect=−2.1; 95% CI, −3.8 to −0.3; 
P=.02) compared with routine primary 
care. Individual CBT also reduced EPDS 
scores, when compared to routine pri-
mary care (N=55; treatment effect=−2.7; 
95% CI, −4.5 to −0.9; P=.003). 
Psychodynamic therapy reduced the 
proportion of women with major depres-
sion (N=55; RR=1.89; 95% CI, 1.33-
2.33).
All of these interventions improved 
PPD immediately following treatment 
compared with routine primary care, but 
the benefits were not sustained at long-
term follow-up (6 months). Study limita-
tions included failure to control for mul-
tiple comparisons, pretreatment group 
differences, differential attrition among 
groups, and lack of sufficient power. 
A later RCT (N=121) also found 
psychological interventions (group CBT 
and group and individual counseling) 
to be superior to routine primary care, 
with individual counseling yielding the 
greatest improvement in PPD symptoms 
(P<.05).4
Antidepressants	vs	CBT:		
Too	little	information
Two RCTs compared antidepressant 
medications to CBT.3 In the first (N=87), 
fluoxetine and placebo were each paired 
with 1 or 6 CBT sessions. After 12 weeks 
of treatment, fluoxetine was superior to 
placebo as measured by mean symptom 
score reduction on the HAM-D, EPDS, 
and clinical interview schedule; 6 CBT 
sessions were superior to a single session 
as measured by mean symptom score 
reduction on the Hamilton Depression 
Scale and clinical interview schedule.5 No 
significant interaction effect was found. 
The authors reported “highly signifi-
cant” improvements, but didn’t specify 
significance level or provide adequate 
information to calculate number needed 
to treat. Interpretation of the findings 
is limited by methodologic weaknesses, 
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high withdrawal rate, and exclusion of breast-
feeding women.3
A second, small RCT (N=35) compared 12 
weeks of paroxetine with a combination of par-
oxetine and CBT.6 Significant improvements—
defined as percentage of patients in each group 
demonstrating at least a 50% score reduction 
on the HAM-D (paroxetine, 87.5%; combina-
tion, 78.9%) and EPDS (paroxetine, 61.5%; 
combination, 58.3%)—occurred in both groups 
(P<.01), but no difference was found between 
the groups. The study didn’t include a placebo 
control group. 
Recommendations
The National Collaborating Centre for Wom-
en’s and Children’s Health recommends against 
offering educational interventions to pregnant 
women because such interventions haven’t been 
found to reduce PPD.7 
The Scottish Intercollegiate Guidelines Net-
work recommends “postnatal visits, interper-
sonal therapy, and/or antenatal preparation” 
to prevent PPD. To treat PPD, they recommend 
psychosocial interventions, preferably those 
that include more than 1 family member.8 n
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IN THE UNITED STATES,  
THE PRESS CANNOT BE CENSORED. 
THE INTERNET CANNOT BE CENSORED. 
POLITICAL ADVERTISING CANNOT  
BE CENSORED. 
WHY ARE SOME MEMBERS OF  
CONGRESS & ACADEMIA TRYING TO  
CENSOR MEDICAL COMMUNICATIONS?
Diabetes. Cancer. Obesity.  
Respiratory disease. America’s  
medical professionals are busier  
than ever. How can they stay current 
with medical advances and still  
improve their patients’ well-being? 
Information is part of quality care.  
Yet government controls threaten  
to keep doctors in the dark about  
current medical advances. 
Restrictions on how much  
information consumers and doctors 
can know about current and new 
treatments reduce their ability to 
advocate for care. 
Using censorship as a policy tool 
to control healthcare costs is a bad 
idea! Yet that’s what vocal pockets of 
academic medicine and Congress 
have in mind. 
We are concerned that some mem-
bers of Congress and academia are 
seeking to restrict the content of 
CME and other industry-sponsored 
communications without input from 
practicing physicians.
This message brought to you as a public service  
by the Coalition for Healthcare Communication.
a d v e r t i s e m e n t
Information is the first step to care. To learn more, visit cohealthcom.org. 
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